ARCHIVES

EntreMed Begins Phase I/II Trial For Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Time-Out For A New Sense Of Cooperation, Urgency.

January 21, 2000

GA Draft Report Lukewarm On Cancer Survival Improvement; NCI Says It Is “Opinion, Not Fact”

April 3, 1987

Includes April issue of Business & Regulatory Report (8 pages).

May 2, 2003

1985 International Cancer Congress to Be In Budapest

September 24, 1982

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

October 22, 2010

Bypass Budget Omits Needless Words: Faster Progress to Cost $421 Million More

March 29, 1996